



General Pro  Regulation Anti Regulations





Loss of Investor Interest in 
Pharmaceutical Industry





General Assembly at IMSA, partnership with IMSA 
Medical Society (student club on campus)
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× https://www.patientsforaffordabledrugs.org
× https://protectmedicine.com/
× https://www.fda.gov/news-events/fda-brief/fda-brief-fda-issues-63-product-specific-
guidances-promote-generic-drug-access-and-drug-price
× https://www.fda.gov/about-fda/center-drug-evaluation-and-research/frequently-ask
ed-questions-about-cder
× https://www.biopharmadive.com/news/fda-scott-gottlieb-confronts-limits-drug-prici
ng-push/530724/
× https://www.nber.org/papers/w12676
× https://www.fda.gov/drugs/development-approval-process-drugs/laws-regulations-p
olicies-and-procedures-drug-applications
× https://www.commonwealthfund.org/sites/default/files/documents/___media_files_pu
blications_issue_brief_2017_oct_sarnak_paying_for_rx_ib_v2.pdf
× https://www.who.int/sdg/targets/en/

